Inhibition of the Chinese prescription "Shen Yang" on human tongue cancer in BALB/C-nu/nu mice in vivo

邱蔚六,张秀丽,蒋灿华,叶冬霞,周晓健,陈万涛
DOI: https://doi.org/10.3969/j.issn.1672-3244.2004.01.008
2004-01-01
Abstract:PURPOSE:Prospective research demonstrated that the Chinese priscriptionShen Yangcould prolong the survival days and increase the survival rate of patients with oral squamous cell carcinoma,but its mechanism was still un-clear.The purpose of this study was to explore the anti-tumor effect of Chinese prescriptionShen Yangon human tongue cancer in BALB/C-nu/nu mice and research on its mechanisms.METHODS:Human tongue cancer cell line-Tca8113cells that grew logarithmically were transplanted subcutaneously to BALB/C-nu/nu mice and model of xenoplant-ed tumor was established.48mice were divided randomly into four groups,including the group ofShen YangA,Shen YangB,positive control and negative control.Different dosages of drugs were given respectively for thirty days.The ef-fects ofShen Yangon the tumor growth,living state,survival days and spleen index were observed and calculated.RE-SULTS:72.8mg ofShen Yanggiven to each mouse every day could partially inhibit the growth of transplanted tumors by22.04%with no obvious toxic side effects on the main organs.Spleen index of nude mice increased significantly(t test,P0.05).The survival time was prolongated by18.9%.CONCLUSION:The direct anti-tumor effect ofShen Yangwas weak to mice bearing squamous cell carcinoma.Its major mechanism might be that Chinese prescriptionShen Yangim-prove immunological function in vivo.
What problem does this paper attempt to address?